Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign In
  • Home
  • World
    Sections
    • World Home
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • UK inflation holds steady at 2.2% in August
    • Why Europe will not catch up with the US
    • Nine killed and thousands injured as Hizbollah pagers explode in Lebanon
    • Exploding pagers join long history of killer communications devices
    • Charlie Mullins is back on Pimlico Plumbers’ home turf
  • US
    Sections
    • US Home
    • US Economy
    • Investing in America
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2024
    Most Read
    • Why Europe will not catch up with the US
    • Kamala Harris admits she still has ‘to earn’ the Black male vote
    • Market speculation about the next Fed rate cut masks deeper issues
    • Music mogul Sean Combs charged with racketeering and sex trafficking
    • US delays decision on Nippon Steel’s $15bn takeover of US Steel
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • The fury of the frequent flyer
    • BlackRock and Microsoft plan $30bn fund to invest in AI infrastructure
    • Steve Cohen to step back from trading at hedge fund Point72
    • Reeves orders crackdown on government use of consultants
    • EU competition chief warns against weakening rules to create champions
  • Tech
    Sections
    • Tech Home
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
    Most Read
    • BlackRock and Microsoft plan $30bn fund to invest in AI infrastructure
    • Meta faces hefty EU antitrust fine over classified ads practices
    • ‘No Man’s Sky’ and ‘Cyberpunk 2077’ show there is life after death for video-game flops
    • Amazon orders staff back to office five days a week
    • Data centres must work ‘within climate limits’, says Irish minister
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Crypto
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
    Most Read
    • BlackRock and Microsoft plan $30bn fund to invest in AI infrastructure
    • Steve Cohen to step back from trading at hedge fund Point72
    • BP’s US wind sale will not clear its strategic fog
    • Switzerland’s SIX explores launching crypto exchange
    • Vibes on the big day
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Why Europe will not catch up with the US
    • The fury of the frequent flyer
    • Charlie Mullins is back on Pimlico Plumbers’ home turf
    • Draghi is trying to save Europe from itself
    • BP’s US wind sale will not clear its strategic fog
  • Lex
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
    Most Read
    • Amazon orders staff back to office five days a week
    • FT and Schroders Business Book of the Year 2024 — the shortlist
    • Italy retains allure for rich Europeans fleeing higher taxes
    • The problem with panels
    • Tata chair on ‘painful’ transitions: ‘We have to do this’
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Thoroughly modern Mayfair
    • Why every man needs a smart black hoodie
    • ‘No Man’s Sky’ and ‘Cyberpunk 2077’ show there is life after death for video-game flops
    • Tramp revamped: the return of a legendary nightclub
    • The brothers trying to save the British fountain pen
  • HTSI
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Lex
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

US opioid epidemic

  • Wednesday, 7 August, 2024
    China imposes restrictions on fentanyl chemicals after pressure from US

    Move is the first time in six years that Beijing will restrict the ingredients used in the drug

    A pill is seen pressed from a pill press
  • Wednesday, 3 July, 2024
    Potent overdose treatment boosts hopes of combating opioid crisis

    New compound increases strength of antidote for fentanyl and other lethal drugs

    A person using fentanyl
  • Friday, 28 June, 2024
    Due Diligence
    Purdue: the ‘chaos’ coming for bankruptcy Premium content

    Plus, troubles are brewing among loans favoured by private equity, and venture capital makes a big bet on defence tech

    Bottle of Oxycontin
  • Thursday, 27 June, 2024
    Purdue Pharma LP
    US Supreme Court rejects plan to shield Sacklers in Purdue bankruptcy

    Members of OxyContin maker’s founding family had fought to uphold protections in $6bn opioid settlement

    A bottle of OxyContin
  • Monday, 29 April, 2024
    Drug prices
    California moves to cut medicine prices with novel deal on opioid overdose drugs

    US state to buy naloxone nasal spray from generics maker and distribute medication under its own brand

    California governor Gavin Newsom
  • Friday, 26 April, 2024
    Special ReportThe Americas’ Fastest Growing Companies
    Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis

    With revenues having more than doubled since 2019, to $10bn, US pharma group targets painkillers

    Kayla Krumrey, 21, of St. Charles, holds up a pill that she takes for her cystic fibrosis
  • Wednesday, 24 April, 2024
    McKinsey
    McKinsey faces US criminal investigation over opioid industry work

    Grand jury set up to hear evidence on consulting for drugmakers tied to addiction epidemic

    McKinsey & Company logo
  • Friday, 2 February, 2024
    Publicis to pay $350mn to settle US opioid crisis case

    Agreement with French group is the first prosecutors have made with an advertising agency over its alleged role

    Addicts on a US street
  • Monday, 29 January, 2024
    US-China relations
    US and Chinese officials to discuss crackdown on fentanyl precursors

    Beijing meeting aims to advance agreements between Joe Biden and Xi Jinping during summit last year

    Capsules with methamphetamine being prepared in a safe house in Mexico
  • Monday, 4 December, 2023
    Purdue Pharma LP
    US Supreme Court grapples with Sackler liability releases in Purdue bankruptcy

    Members of the company’s founding family fight to uphold protections from $6bn opioid bankruptcy settlement in closely watched case

    A pharmacist holds a bottle of OxyContin
  • Tuesday, 14 November, 2023
    US-China relations
    China and US to agree crackdown on fentanyl trade

    Plan to curb supply of opioid’s precursor chemicals comes ahead of summit between Joe Biden and Xi Jinping

    A display of fentanyl and methemphetamine seized by Customs and Border Protection officers at the Nogales Port of Entry in Arizona
  • Wednesday, 8 November, 2023
    Visual story
    The global network behind the fentanyl crisis

    The illicit trade routes responsible for the worst overdose crisis in US history

  • Wednesday, 4 October, 2023
    A toxic mix: opioid victims’ $1bn hit from repeat pharma bankruptcy

    Hedge funds seize control of Mallinckrodt in latest case exposing flaws of US mass tort playbook

    People protest in front of the White House to raise awareness of opioid-related deaths
  • Tuesday, 3 October, 2023
    US takes aim at fentanyl with sanctions on China-based network

    Treasury’s move comes as Washington tries to combat flow of deadly opioid

    Plastic bags of fentanyl
  • Wednesday, 27 September, 2023
    McKinsey
    McKinsey pays out another $230mn to settle opioid cases

    Consultancy admits no wrongdoing as it resolves claims from municipalities and school districts

    OxyContin pills
  • Monday, 18 September, 2023
    OutlookPatti Waldmeir
    Tactics are shifting in the war on drugs

    Experimentation continues on measures to tackle addiction and fatal overdoses

    A box containing naloxone overdose emergency kits outside a store at Canal Park in Pennsylvania
  • Wednesday, 23 August, 2023
    Lex
    Mallinckrodt: legal rejig may slash $1.1bn from opioid victims’ trust Premium content

    Drug producer’s prospects are poor enough that its reset enterprise value is just $3bn

    Homeless people are seen on streets of  Kensington, Philadelphia
  • Friday, 11 August, 2023
    ReviewTelevision
    Painkiller is a surprisingly watchable drama about the opioid crisis

    The new six-part Netflix series is a comprehensive and pacy examination of mass greed and its consequences

    A man with grey hair and a grey suit stands outside a grand building in front of a microphone as it snows, two men in black suits flanking him.
  • Thursday, 10 August, 2023
    Purdue Pharma LP
    Supreme Court halts $6bn Purdue opioid settlement in blow to Sacklers

    Justices will consider whether the law permits the waiver of future claims against parties not in bankruptcy

    A pharmacist holds a bottle of OxyContin
  • Monday, 12 June, 2023
    Inside BusinessSujeet Indap
    Opioid victims fear the pain of junior creditor status at Mallinckrodt

    Payouts at risk of falling below other creditors in any repeat bankruptcy

    30mg pills of the painkiller Oxycodone Hydrochloride
  • Wednesday, 31 May, 2023
    News in-depth
    ‘People rot from the inside out’: lethal xylazine deepens the US drug crisis

    Cartels are cutting fentanyl with the cheap sedative, driving a surge in overdoses in cities such as Philadelphia

    A nurse practitioner treats wounds on a patient
  • Tuesday, 30 May, 2023
    Purdue Pharma allowed to shield Sackler owners from opioid lawsuits

    Appeals court says some liability releases are ‘appropriate’ under US bankruptcy law

    A bottle of OxyContin made by Purdue Pharma
  • Friday, 26 May, 2023
    Cryptofinance
    Crypto’s dark role in the US opioid epidemic

    Plus, losses to crypto fraud rises and update on Do Kwon

    An image of a fentanyl syringe
  • Thursday, 18 May, 2023
    FT Magazine
    What if San Francisco never pulls out of its ‘doom loop’?

    A crisis of homelessness, drug abuse and sensationalised crime threaten the city’s future

  • Tuesday, 16 May, 2023
    University of Oxford
    Oxford university drops Sackler name from buildings after investigation

    Decision comes at end of review instigated by new vice-chancellor Irene Tracey

    A view of the Radcliffe Camera building, part of the Bodleian Library, in Oxford
Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsSubscription ManagerNews feedNewslettersCurrency Converter

Community & Events

FT Live EventsFT ForumsBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2024. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Edition:International
UK
Subscribe for full access

Top sections

  • Home
  • World
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
  • US
    • US Economy
    • Investing in America
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2024
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
  • Markets
    • Alphaville
    • Markets Data
    • Crypto
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Lex
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Alphaville
  • FT Edit
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • FT Digital Edition
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In